First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL69057
U.S. Department of Veterans Affairs
Grant: BX004270
Veterans Health Administration Biomedical Laboratory Research and Development
GEn1E Lifesciences
Institute for Clinical and Translational Research, University of Wisconsin, Madison
Keywords